Beam Therapeutics Inc (BEAM)

NASDAQ · Biotechnology

23.47
-1.26 (-5.10%)
Updated Oct 17, 6:39 AM ET
AI Rating
Sell
Overall Score
34
Trend
0
Momentum
57
Risk
58

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 1, 2025 260 sessions Oct 13, 2026

AI Analysis

Beam Therapeutics Inc is trading at $23.47, down 5.10% on the session. The 50 day average sits at $26.48 and the 200 day at $28.41, which puts the stock in a downtrend. RSI is at 43.9, which reads as weak, and MACD is bullish crossover. Volume is below average.

The nearest support is around $23.83 with resistance near $26.50, so that band frames the current range. Average daily movement is roughly $1.38, or about 5.9% of the share price, which is what any stop placement has to allow for. The overall health score of 34 out of 100 combines a trend score of 0, momentum of 57 and a risk score of 58.

Technical indicators

RSI (14)
43.9
weak
MACD
-0.419
bullish crossover
SMA 20
24.74
SMA 50
26.48
SMA 200
28.41
downtrend
ATR (14)
1.38
avg daily range
Support
23.83
Resistance
26.50
Volume vs 20d
0.87x
below average
Volatility
45.6%
annualised
1 month
+1.29%
3 months
-20.79%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.